PNSCX
Price
$63.98
Change
-$0.56 (-0.87%)
Updated
Sep 12 closing price
Net Assets
3B
WCMNX
Price
$13.48
Change
-$0.22 (-1.61%)
Updated
Sep 12 closing price
Net Assets
44.71M
Interact to see
Advertisement

PNSCX vs WCMNX

Header iconPNSCX vs WCMNX Comparison
Open Charts PNSCX vs WCMNXBanner chart's image
Putnam Small Cap Growth C
Price$63.98
Change-$0.56 (-0.87%)
VolumeN/A
Net Assets3B
WCM Small Cap Growth Investor
Price$13.48
Change-$0.22 (-1.61%)
VolumeN/A
Net Assets44.71M
PNSCX vs WCMNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PNSCX vs. WCMNX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PNSCX is a Buy and WCMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PNSCX has more cash in the bank: 3B vs. WCMNX (44.7M). PNSCX (0.00) and WCMNX (0.00) have matching dividends . PNSCX was incepted earlier than WCMNX: PNSCX (24 years) vs WCMNX (6 years). WCMNX (2.04) and PNSCX (1.96) have similar cost to investors . WCMNX is a more actively managed with annual turnover of: 83.00 vs. PNSCX (40.00). PNSCX has a lower initial minimum investment than WCMNX: PNSCX (0) vs WCMNX (1000). PNSCX annual gain was more profitable for investors over the last year : 10.46 vs. WCMNX (7.41). PNSCX return over 5 years is better than : 33.96 vs. WCMNX (22.77).
PNSCXWCMNXPNSCX / WCMNX
Total Expense Ratio1.961.24158%
Annual Report Gross Expense Ratio1.962.0496%
Fund Existence24 years6 years-
Gain YTD8.6066.225138%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets3B44.7M6,707%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.467.41141%
Returns for 3 years54.0923.78227%
Returns for 5 years33.9622.77149%
Returns for 10 years134.88N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWBO0.260.01
+3.51%
Northwest Biotherapeutics, Inc.
HCBN36.75N/A
N/A
H.C.B. Financial Corp.
LFABF36.00N/A
N/A
Lifco AB
ANSLY90.19N/A
N/A
Ansell Ltd.
SPTY0.11-0.05
-30.04%
Specificity, Inc.